Uncategorised - European Medical Journal

The latest advances in prostate cancer research

On the final day of EAU22 in Amsterdam, experts stepped away from the action to present highlights in prostate cancer treatment from this year’s congress.

Benefits of Placebo in Paediatric Abdominal Pain

Findings show that using an OLP resulted in significant reduction in mean pain scores as well as a reduction in the use of rescue medication…

Predicting Type 2 Diabetes Remission in Patients of Gastric Bypass

Blood ceramide levels could help predict whether patients with Type 2 diabetes who undergo gastric bypass surgery will experience remission…

Male Sex Hormones Linked to Bladder Cancer Disparities

Male sex hormones have been shown to hinder the body’s ability to combat bladder cancer. Read to find out more…

Could Focal Treatment for Intermediate-Risk Prostate Cancer Improve Outcomes?

Researches show MRI-guided HIFU to deliver focal therapy could improve quality of life for patients with intermediate-risk prostate cancer…

The Value of Evidence-Based Medicine

In this week’s episode, Jonathan is joined by Uwe Gudat, Chief Medical Officer, Aretaeus Sàrl, Geneva, Switzerland.

Editor’s Pick: Impact of COVID-19 on Diagnostic Delay in Rare Disease

Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the diagnostic odyssey’.

Insights into Newly Diagnosed Multiple Myeloma Treatment Options

Novel trial results show a more effective treatment route for newly diagnosed multiple myeloma. Read now for more details…

Three-Cycle Chemotherapy Regimen for Chronic Lymphocytic Leukaemia

New research shows that a three-cycle regimen of chemotherapy is an effective first-line treatment for patients with CLL. Read more…

Key Insights from EULAR 2022: An Interdisciplinary Expert Roundtable Discussion

IME Rheumatology Webinar | Key Insights from EULAR 2022 - An Interdisciplinary Expert Roundtable Discussion

Watch our roundtable discussion to gain a deeper understanding of emerging data from the EULAR 2022 congress.